Safety and Efficacy of Intra-articular Ozone Injections for Knee Osteoarthritis
Primary Purpose
Osteoarthritis Knee
Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Ozone gas
Steroid injection
Sponsored by
About this trial
This is an interventional treatment trial for Osteoarthritis Knee
Eligibility Criteria
Inclusion Criteria:
- 55 to 79 years of age
- Symptomatic Knee osteoarthritis
- VAS pain intensity is at least 40 mm on a 100 mm scale
- Must be physically and mentally willing and able to comply with post-operative rehabilitation and routinely schedule clinical and radiographic visits.
Exclusion Criteria:
- Any known tumor of the ipsilateral knee.
- Any known infection of the treated knee.
- Osteoarthritis of the operated knee Kelgren Lawrence < grade 2.
- Chemotherapy treatment in the past 12 months.
- Patients who are sensitive to ozone.
- Pregnant women, or breastfeeding women.
- Evidence of any significant systemic disease (such as but not limited to HIV infection, hepatitis infection or HTLV infection), known coagulopathies, that might compromise the Subject's welfare.
- Substance abuse or alcohol abuse.
- Participation in other clinical trials in parallel to this study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
OZONE
control
Arm Description
injection of ozone gas
injeciton of steroids intra articularly
Outcomes
Primary Outcome Measures
Improvement in VAS Pain intensity
The outcome measure will be measured according to patient response to the question: during the last week what was your average pain intensity. The response will be measured in millimeters as marked on a 10 cm long line. No pain equals 0 mm and maximal possible pain equals 100mm
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02833545
Brief Title
Safety and Efficacy of Intra-articular Ozone Injections for Knee Osteoarthritis
Official Title
Safety and Efficacy of Intra-articular Ozone Injections for Knee Osteoarthritis
Study Type
Interventional
2. Study Status
Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
September 1, 2016 (Actual)
Primary Completion Date
May 31, 2018 (Actual)
Study Completion Date
August 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rabin Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Prospective, Interventional, Non-Randomized, Open Label, Single Group Assignment, Single Center.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis Knee
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Sequential Assignment
Model Description
A sequential series of patients receiving steroid injections was compared to a sequential series of patients receiving ozone injections
Masking
InvestigatorOutcomes Assessor
Masking Description
the outcome assessor was not aware of the therapy administered
Allocation
Non-Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
OZONE
Arm Type
Experimental
Arm Description
injection of ozone gas
Arm Title
control
Arm Type
Active Comparator
Arm Description
injeciton of steroids intra articularly
Intervention Type
Device
Intervention Name(s)
Ozone gas
Intervention Description
Injection of ozone gas intra articularly
Intervention Type
Drug
Intervention Name(s)
Steroid injection
Intervention Description
Injection of steroids (diprospan) intra articularly
Primary Outcome Measure Information:
Title
Improvement in VAS Pain intensity
Description
The outcome measure will be measured according to patient response to the question: during the last week what was your average pain intensity. The response will be measured in millimeters as marked on a 10 cm long line. No pain equals 0 mm and maximal possible pain equals 100mm
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
55 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
55 to 79 years of age
Symptomatic Knee osteoarthritis
VAS pain intensity is at least 40 mm on a 100 mm scale
Must be physically and mentally willing and able to comply with post-operative rehabilitation and routinely schedule clinical and radiographic visits.
Exclusion Criteria:
Any known tumor of the ipsilateral knee.
Any known infection of the treated knee.
Osteoarthritis of the operated knee Kelgren Lawrence < grade 2.
Chemotherapy treatment in the past 12 months.
Patients who are sensitive to ozone.
Pregnant women, or breastfeeding women.
Evidence of any significant systemic disease (such as but not limited to HIV infection, hepatitis infection or HTLV infection), known coagulopathies, that might compromise the Subject's welfare.
Substance abuse or alcohol abuse.
Participation in other clinical trials in parallel to this study.
12. IPD Sharing Statement
Learn more about this trial
Safety and Efficacy of Intra-articular Ozone Injections for Knee Osteoarthritis
We'll reach out to this number within 24 hrs